SOPHiA GENETICS (SOPH) CTO sells shares to cover tax withholding

Rhea-AI Filing Summary

SOPHiA GENETICS SA Chief Technology Officer Abhimanyu Verma sold 6,944 Ordinary Shares in an open-market transaction at a weighted average price of about $5.51 per share. According to the disclosure, the sale was made to cover tax withholding obligations from restricted stock unit vesting under a pre-established Rule 10b5-1(c) trading plan and was not a discretionary trade. Following this tax-related sale, he continues to hold 197,456 Ordinary Shares directly.

Insider Trade Summary 10b5-1

Net Seller: 6,944 shares ($38,229)

Net Sell 1 txn

Insider Verma Abhimanyu

Role Chief Technology Officer

Sold 6,944 shs ($38K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	6,944	$5.5054	$38K

Holdings After Transaction: Ordinary Shares — 197,456 shares (Direct, null)

Footnotes (1)

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.31 to $5.69, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 6,944 shares Weighted average sale price: $5.5054 per share Post-transaction holdings: 197,456 shares +1 more

4 metrics

Shares sold 6,944 shares Ordinary Shares sold on June 25, 2026 in open market

Weighted average sale price $5.5054 per share Open-market sale of Ordinary Shares

Post-transaction holdings 197,456 shares Ordinary Shares held directly after the sale

Sale price range $5.31–$5.69 per share Range of individual trade prices within the reported sale

Key Terms

restricted stock units, Rule 10b5-1(c) trading plan, weighted average price, open market

4 terms

restricted stock units financial

"tax withholding obligations arising in connection with the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 10b5-1(c) trading plan regulatory

"These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan"

A Rule 10b5-1(c) trading plan is a legally defined, pre-set schedule that lets company insiders automatically buy or sell stock at specified times or under set formulas when they are not in possession of undisclosed, sensitive information. Think of it like an automatic payment plan for trades: because the instructions are written in advance, trades under the plan help protect insiders from allegations of trading on secret information and give investors clearer expectations about when insiders will transact, which can affect liquidity and perceived transparency.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market financial

"Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations"

An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/26/2026 - 04:03 PM Accepted by SEC EDGAR 06/26/2026 - 04:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Verma Abhimanyu

(Last) (First) (Middle)

C/O SOPHIA GENETICS SA

LA PIECE 12

(Street)

ROLLE 1180

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/25/2026		S		6,944(1)	D	$5.5054(2)	197,456	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.31 to $5.69, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Elimara Brunetto as Attorney-in-fact for Abhimanyu Verma	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did SOPHiA GENETICS (SOPH) CTO Abhimanyu Verma report in this Form 4?

Abhimanyu Verma reported selling 6,944 Ordinary Shares of SOPHiA GENETICS. The sale was an open-market transaction tied to tax withholding from restricted stock unit vesting, executed under a pre-established Rule 10b5-1(c) trading plan.

How many SOPHiA GENETICS (SOPH) shares did the CTO sell and at what price?

He sold 6,944 Ordinary Shares at a weighted average price of $5.5054 per share. The filing notes multiple individual trades occurred within a $5.31 to $5.69 price range, producing the reported weighted average sale price.

Why did the SOPHiA GENETICS (SOPH) CTO sell shares in this transaction?

The sale was made to satisfy tax withholding obligations arising from the vesting of restricted stock units. The filing explains these shares were sold specifically for tax purposes, rather than as a discretionary change in his investment position.

Was the SOPHiA GENETICS (SOPH) CTO’s share sale under a Rule 10b5-1 trading plan?

Yes, the sale was executed under a pre-established Rule 10b5-1(c) trading plan adopted by the CTO. Such plans schedule trades in advance, meaning the timing of these sales was not discretionary or based on recent market developments.

How many SOPHiA GENETICS (SOPH) shares does the CTO hold after this Form 4 transaction?

After selling 6,944 shares, the CTO directly holds 197,456 Ordinary Shares. This remaining stake, reported in the filing, shows that the tax-related sale affected only a portion of his overall holdings in the company.

What price range did SOPHiA GENETICS (SOPH) shares sell for in this CTO transaction?

Individual trades occurred at prices between $5.31 and $5.69 per share. The Form 4 reports a weighted average sale price of $5.5054 and states full trade-by-trade pricing details are available on request from the company or regulators.